Creating a Culture of Clinical Trial Inspection Readiness

Creating a Culture of Clinical Trial Inspection Readiness

When a culture of readiness is embedded within an organisation, the greatest level of inspection readiness can be maintained.We wanted to gain a greater understanding of the most important elements to consider when creating a culture of readiness including the training, documentation maintenance and vendor management during the clinical trial. 

In this exclusive interview with Nancy Meyerson-Hess, Chief Compliance and Regulatory Officer, eMQT and Former Head of Clinical Operations and Compliance, Grünenthal we discuss the challenges and solutions of creating and maintaining a a culture of Clinical Trial Inspection Readiness. 


Please note: That all fields marked with an asterisk (*) are required.



This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.